These studies show that targeting PHGDH can not only directly intervene in tumour cell survival and proliferation through classical metabolic pathways or nonclassical pathways but also increase the sensitivity of cells to other drugs, indicating that it may be a promising therapeutic target in tumour treatment. Here, PHGDH is linked to neoplasm.